Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.65 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | MGLL | Q99685 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.35 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.35 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.35 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.35 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27762045 | 0.89 | ALDH1A1 (0.58) | ALDH1A1TSHRTDP1HDAC8CHRNB2 | |
| SCHEMBL1024003 | 0.82 | ALDH1A1 (0.65) | ALDH1A1TSHRTDP1HDAC8HPGD | |
| SCHEMBL473081 | 0.80 | ALDH1A1 (1.00) | ALDH1A1TSHRTDP1HDAC8MAPT | |
| SCHEMBL7639 | 0.80 | ALDH1A1 (1.00) | ALDH1A1TSHRTDP1HDAC8MAPT | |
| Lithium SCHEMBL30427541 | 0.80 | ALDH1A1 (0.61) | ALDH1A1TSHRTDP1HDAC8HPGD | |
| SCHEMBL16652461 | 0.79 | ALDH1A1 (0.46) | ALDH1A1TSHRTDP1HDAC8CHRNB2 | |
| SCHEMBL98657 | 0.78 | ALDH1A1 (0.58) | ALDH1A1TSHRHDAC8MAPTSMN1; SMN2 | |
| SCHEMBL18726334 | 0.78 | ALDH1A1 (0.58) | ALDH1A1TSHRTDP1HDAC8CHRNB2 | |
| SCHEMBL20609645 | 0.78 | ALDH1A1 (0.58) | ALDH1A1TSHRTDP1HDAC8CHRNB2 | |
| SCHEMBL18649595 | 0.78 | ALDH1A1 (0.58) | ALDH1A1TSHRTDP1HDAC8CHRNB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115954539-A | Self-healing mesh polymer electrolyte, preparation method and application thereof, and polymer lithium battery | 吉林省翰驰科技有限公司 | 2023-04-11 | — | — | CN | claimed |
| WO-2017187279-A1 | HEALABLE THERMOPLASTIC RESINS | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2017-11-02 | — | — | WO | claimed |
| CN-115954539-B | Self-healing reticular polymer electrolyte, preparation method and application thereof, and polymer lithium battery | 吉林省东驰新能源科技有限公司 | 2025-01-28 | — | — | CN | disclosed |
| WO-2023079966-A1 | CROSSLINKABLE RESIN COMPOSITION AND CURED ARTICLE | DIC株式会社 | 2023-05-11 | — | — | WO | disclosed |
| CN-115954539-A | Self-healing mesh polymer electrolyte, preparation method and application thereof, and polymer lithium battery | 吉林省翰驰科技有限公司 | 2023-04-11 | — | — | CN | disclosed |
| US-10821082-B2 | Disintegratable core/shell silica particles for encapsulating and releasing bioactive macromolecules | UNIVERSITE DE STRASBOURG (FR) | 2020-11-03 | — | — | US | disclosed |
| US-10450423-B2 | Disintegratable porous organometaloxyde material | UNIVERSITE DE STRASBOURG (FR) | 2019-10-22 | — | — | US | disclosed |
| WO-2017187279-A1 | HEALABLE THERMOPLASTIC RESINS | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2017-11-02 | — | — | WO | disclosed |
| WO-2017187279-A1 | HEALABLE THERMOPLASTIC RESINS | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2017-11-02 | — | — | WO | disclosed |
| US-20170119688-A1 | Disintegratable Core/Shell Silica Particles for Encapsulating and Releasing Bioactive Macromolecules | UNIVERSITE DE STRASBOURG (FR) | 2017-05-04 | — | — | US | disclosed |
| JP-2009249357-A | 1-VINYL-4-[(4-VINYLPHENYL)DISULFANYL]BENZENE DERIVATIVE | TOYO KASEI KOGYO CO LTD | 2009-10-29 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10450423-B2 | Disintegratable porous organometaloxyde material | MCM4, SI, ESD | ALDH1A1 3969/4885TSHR 4866/4885TDP1 1811/4885 |
| US-10821082-B2 | Disintegratable core/shell silica particles for encapsulating and releasing bioactive macromolecules | VIP, ADAM9, ADAM17 | ALDH1A1 4638/4885TSHR 3613/4885TDP1 2961/4885 |
| US-20170119688-A1 | Disintegratable Core/Shell Silica Particles for Encapsulating and Releasing Bioactive Macromolecules | VIP, ADAM9, ADAM17 | ALDH1A1 4638/4885TSHR 3613/4885TDP1 2961/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.